{
  "permutation_id": "P5e-S4",
  "description": "eldelumab reclassification + PSR with (1-Tm) tiebreaker",
  "reclassification": {
    "tier_a_psr": [
      "bimagrumab",
      "bavituximab",
      "ganitumab"
    ],
    "tier_b_tm": [
      "eldelumab"
    ],
    "tier_c_clinical": [
      "infliximab"
    ]
  },
  "removal_strategy": "PSR primary, (1-Tm) secondary for PSR=0",
  "reclassified_ids": [
    "bimagrumab",
    "bavituximab",
    "ganitumab",
    "eldelumab",
    "infliximab"
  ],
  "removed_ids": [
    "olaratumab",
    "basiliximab",
    "rituximab",
    "benralizumab",
    "dinutuximab",
    "pembrolizumab",
    "fezakinumab",
    "reslizumab",
    "ipilimumab",
    "lirilumab",
    "muromonab",
    "abituzumab",
    "glembatumumab",
    "rilotumumab",
    "tralokinumab",
    "tremelimumab",
    "lumiliximab",
    "nivolumab",
    "radretumab",
    "tigatuzumab",
    "zanolimumab",
    "enokizumab",
    "obinutuzumab",
    "crenezumab",
    "atezolizumab",
    "pinatuzumab",
    "anifrolumab",
    "drozitumab",
    "girentuximab",
    "bevacizumab"
  ],
  "confusion_matrix": [
    [
      40,
      19
    ],
    [
      10,
      17
    ]
  ],
  "accuracy": 0.6627906976744186,
  "exact_match_to_novo": true,
  "timestamp": "2025-11-03T23:33:17.127730"
}